L'Oreal Group: Commitment to carbon neutrality of all its facilities by 2025
ACI expects healthcare antiseptic manufacturers to lose most active ingredients
The US Food and Drug Administration (FDA) will ban some 80% of active ingredients currently allowed for use in healthcare antiseptics, the American Cleaning Institute (ACI) expects.
Plans to require manufacturers to submit data demonstrating the safety and efficacy of their antibacterial ingredients were set out in a 2015 proposed rule - and are expected to become law when the final rule is issued. The FDA will assess data submitted by industry and decide whether to classify actives as "generally recognised as safe and effective" (Gras/Grae), or ban their use in the products.
ACI expects triclosan to face a ban in healthcare products as well, along with more than 20 other ingredients, its associate vice president for environmental safety, Paul DeLeo, told CW+BiocidesHub.
Some substances will be banned due to a lack of support by industry, he said. "Companies know it won't get FDA approval so they are not willing to do the additional testing the agency is requiring."
Others will fail because the data to support them is too challenging to generate. The agency, he says, is asking for "new methods that we are not aware of anyone having successfully completed in this space", but it has been willing to give companies more time.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
2026-07-09
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
L'Oréal to Invest $80 Million in Mexico Factory Expansion
-
L'Oréal's Performance in the First Half of 2025 Was Solid: Growth Across All Business Lines and Continued Improvement in Profit Margins
-
L'Oréal Acquires Professional Hair Care Brand Color Wow
-
L'Oréal May Soon Acquire Medik8 for 1 Billion Euros
-
L'Oréal UK sales hit £1.5 billion
-
L'Oréal's SalonCentric Acquires Concept JP
-
L'Oréal's Quarterly Sales Growth Hit a New Low Since the Epidemic Due to the Weak Chinese Market
-
Sanofi Repurchases 2.3% of L'Oréal Shares
-
L'Oréal acquires Korean skincare brand Dr.G from Swiss conglomerate Migros
-
L'Oréal sells Decléor and Saint-Gervais Mont Blanc to Cospal to streamline portfolio
Recommend Reading
-
Rising Naphtha Prices in Japan Drive Up Costs for Diapers, Sanitary Products, and Cosmetics
-
Unilever Sells Kate Somerville Brand to Rare Beauty Brands
-
L Catterton to Acquire Minority Stake in Perfume Company EX NIHILO
-
IMCD Acquires Dong Yang FT, Entering the Korean Beauty Sector
-
French Cosmetics Exports Poised for First Drop in Over Two Decades in 2025
-
Arkema's New Singapore Plant Commences Operations, Tripling Polyamide Capacity
-
Geopolitical Expectations Reversal Drags Down Crude Oil, Wednesday's Plunge Exceeds 5%
-
Supply Shortage Supports Strong Performance in Chinese Metallurgical Coke Market
-
Weak Supply and Demand, Falling Costs: Acrylic Acid Prices Hit New Lows and Stabilize
-
High Inventory Levels Put Pressure on DMF Market